AIDS Therapies

U.S. Patent Issuance Associated With Controlled Release AZT Product for HIV/AIDS

Published in AIDS Weekly, November 24th, 1997

The U.S. Patent Office recently granted a patent covering the use a novel, controlled-release drug delivery system for the administration of zidovudine (AZT), the first line treatment for HIV and AIDS in North America and Europe, and the only treatment currently used in much of the rest of the world.

The patent was issued to Verex Laboratories, Inc., Englewood, Colorado.

James M. Dunn, M.D., Verex, commented, "We are quite pleased with the issuance of this patent which we believes continues to substantiate the progress that we have made in our HIV and AIDS treatment program. In the past year, we have completed Phase III clinical trials on this...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly

Source: AIDS Weekly (1997-11-24)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry